TGFB1 and cardiomyopathy: Since this increased TGFβ signaling seems compatible with the survival of Tgfb3+/− mice, it is possible that adult Tgfb3+/− mice will develop progressive cardiovascular disease such as aortic aneurysm, valvular heart disease, and cardiomyopathy.